Profile picture

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)
Membership: EHRA Member
Follow
Biography
Dr. Ziad Hijazi is an Associate Professor of Cardiology at Uppsala University. He holds a Ph.D. in medical sciences and has extensive experience in clinical research, with emphasis on atrial fibrillation, biomarkers, clinical risk stratification, and precision medicine. He currently serves as Medical Director at Thermo Fisher Scientific, focusing on clinical trials. Dr. Hijazi has also been a national coordinator, steering committee member, and coordinating investigator in several large-scale cardiovascular studies, including clinical events committees, and is an editorial board member of Circulation.
Logo ESC

Contributor content

Pulsed field ablation in persistent atrial fibrillation
Session
Pulsed field ablation in persistent atrial fibrillation
12 April 2026
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
Session
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
2 September 2019
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
Session
Optimising anticoagulation management in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
31 August 2019

ESC 365 is supported by